Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Norley

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|June 19, 2004
[Conference on vaccine development and innovative therapy concepts in HIV/AIDS at the Robert Koch Institute]S Norley
AIDS (London, England)|January 1, 1993
Lack of immune suppression in SIV-infected natural hostsK Cichutek, S Norley
Immunobiology|February 1, 1992
Vaccination against HIVS Norley, R Kurth
Springer Seminars in Immunopathology|January 1, 1997
Simian immunodeficiency virus as a model of HIV pathogenesisS Norley, R Kurth
Current Topics in Microbiology and Immunology|January 1, 1994
Simian immunodeficiency viruses of African green monkeysR Kurth, S Norley
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 1, 1995
Neither whole inactivated virus immunogen nor passive immunoglobulin transfer protects against SIVagm infection in the African green monkey natural hostF Siegel, R Kurth, S Norley
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1994
The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptidesT Vogel, R Kurth, S Norley
AIDS (London, England)|August 1, 1994
The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patientsJ Denner, S Norley, R Kurth
Research in Immunology|October 1, 1994
The activated CD8 T-lymphocyte-derived immunodeficiency-virus-suppressing lymphokine in African green monkeys: evidence for a role in control of infection?J Ennen, S Norley, R Kurth
Reviews of Infectious Diseases|January 1, 1988
Antiviral cytotoxic T lymphocyte induction and vaccinationB T Rouse, S Norley, S Martin
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|June 19, 2004
[Conference on vaccine development and innovative therapy concepts in HIV/AIDS at the Robert Koch Institute]S Norley
AIDS (London, England)|January 1, 1993
Lack of immune suppression in SIV-infected natural hostsK Cichutek, S Norley
Immunobiology|February 1, 1992
Vaccination against HIVS Norley, R Kurth
Springer Seminars in Immunopathology|January 1, 1997
Simian immunodeficiency virus as a model of HIV pathogenesisS Norley, R Kurth
Current Topics in Microbiology and Immunology|January 1, 1994
Simian immunodeficiency viruses of African green monkeysR Kurth, S Norley
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 1, 1995
Neither whole inactivated virus immunogen nor passive immunoglobulin transfer protects against SIVagm infection in the African green monkey natural hostF Siegel, R Kurth, S Norley
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1994
The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptidesT Vogel, R Kurth, S Norley
AIDS (London, England)|August 1, 1994
The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patientsJ Denner, S Norley, R Kurth
Research in Immunology|October 1, 1994
The activated CD8 T-lymphocyte-derived immunodeficiency-virus-suppressing lymphokine in African green monkeys: evidence for a role in control of infection?J Ennen, S Norley, R Kurth
Reviews of Infectious Diseases|January 1, 1988
Antiviral cytotoxic T lymphocyte induction and vaccinationB T Rouse, S Norley, S Martin
Pageof 5